Carson Wealth (CWM LLC)’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Buy |
3,317
+1
| +0% | +$81 | ﹤0.01% | 2491 |
|
|
2025
Q4 | $272K | Buy |
3,316
+2
| +0.1% | +$155 | ﹤0.01% | 2319 |
|
|
2025
Q3 | $232K | Sell |
3,314
-117
| -3% | -$7.91K | ﹤0.01% | 2333 |
|
|
2025
Q2 | $220K | Buy |
3,431
+1
| +0% | +$62 | ﹤0.01% | 2098 |
|
|
2025
Q1 | $218K | Buy |
3,430
+1
| +0% | +$67 | ﹤0.01% | 1868 |
|
|
2024
Q4 | $228K | Hold |
3,429
| – | – | ﹤0.01% | 1741 |
|
|
2024
Q3 | $239K | Hold |
3,429
| – | – | ﹤0.01% | 1666 |
|
|
2024
Q2 | $222K | Hold |
3,429
| – | – | ﹤0.01% | 1536 |
|
|
2024
Q1 | $222K | Hold |
3,429
| – | – | ﹤0.01% | 1465 |
|
|
2023
Q4 | $226K | Hold |
3,429
| – | – | ﹤0.01% | 1369 |
|
|
2023
Q3 | $196K | Hold |
3,429
| – | – | ﹤0.01% | 1321 |
|
|
2023
Q2 | $210K | Hold |
3,429
| – | – | ﹤0.01% | 1230 |
|
|
2023
Q1 | $215K | Sell |
3,429
-21
| -0.6% | -$1.35K | ﹤0.01% | 1172 |
|
|
2022
Q4 | $219K | Sell |
3,450
-254
| -7% | -$16.1K | ﹤0.01% | 1067 |
|
|
2022
Q3 | $218K | Buy |
3,704
+25
| +0.7% | +$1.54K | ﹤0.01% | 1015 |
|
|
2022
Q2 | $212K | Hold |
3,679
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q1 | $228K | Hold |
3,679
| – | – | ﹤0.01% | 990 |
|
|
2021
Q4 | $262K | Buy |
+3,679
| New | +$266K | ﹤0.01% | 920 |
|
|
2021
Q2 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 799 |
|
|
2021
Q1 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 799 |
|
|
2020
Q4 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2020
Q3 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2020
Q2 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2020
Q1 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2019
Q4 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2019
Q3 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2019
Q2 | $284K | Hold |
3,679
| – | – | ﹤0.01% | 798 |
|
|
2019
Q1 | $284K | Buy |
3,679
+480
| +15% | +$25.4K | ﹤0.01% | 798 |
|
|
2018
Q4 | $151K | Hold |
3,199
| – | – | ﹤0.01% | 655 |
|
|
2018
Q3 | $190K | Buy |
3,199
+2,780
| +663% | +$162K | ﹤0.01% | 521 |
|
|
2018
Q2 | $23K | Hold |
419
| – | – | ﹤0.01% | 810 |
|
|
2018
Q1 | $21K | Hold |
419
| – | – | ﹤0.01% | 700 |
|
|
2017
Q4 | $20K | Hold |
419
| – | – | ﹤0.01% | 699 |
|
|
2017
Q3 | $21K | Hold |
419
| – | – | ﹤0.01% | 696 |
|
|
2017
Q2 | $19K | Buy |
419
+1
| +0.2% | +$43 | ﹤0.01% | 641 |
|
|
2017
Q1 | $18K | Hold |
418
| – | – | ﹤0.01% | 619 |
|
|
2016
Q4 | $16K | Buy |
418
+118
| +39% | +$4.76K | ﹤0.01% | 635 |
|
|
2016
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 636 |
|
|
2016
Q2 | $11K | Hold |
300
| – | – | ﹤0.01% | 547 |
|
|
2016
Q1 | $11K | Buy |
+300
| New | +$11.7K | ﹤0.01% | 513 |
|
Other funds holding PBE
UCFA
GKWIM
YIA
Carson Wealth (CWM LLC)'s PBE Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Invesco Biotechnology & Genome ETF (PBE) stake by 0.03% in Q1 2026, buying an estimated $81 and bringing the position to 3,317 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2491.
Carson Wealth (CWM LLC) first reported a position in PBE in Q1 2016 and has held it in 40 quarters since. The position peaked at $284K in Q2 2021. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.
- Carson Wealth (CWM LLC) held 3,317 shares of Invesco Biotechnology & Genome ETF worth $263K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 1 Invesco Biotechnology & Genome ETF share in Q1 2026, an estimated $81.
- Invesco Biotechnology & Genome ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2491 holding.
- Carson Wealth (CWM LLC) first reported a position in Invesco Biotechnology & Genome ETF in Q1 2016 and has held it in 40 quarters since.
- Carson Wealth (CWM LLC)'s Invesco Biotechnology & Genome ETF position peaked at $284K in Q2 2021.
- 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.